Octreotide: Injection (modified release) 10 mg (as acetate); Vial and diluent syringe
injection (modified release) 20 mg (as acetate); Vial and diluent syringe
injection (modified release) 30 mg (as acetate); Vial and diluent syringe; Sandostatin LAR^®

Page last updated: 26 October 2018

• Public Summary Document (PSD) July 2018 PBAC Meeting - (PDF 191 KB)
• Public Summary Document (PSD) July 2018 PBAC Meeting - (Word 77 KB)